Good news! Cancer is history (soon)!
Hopefully, machine learning & AI will dramatically speed up the process of developing powerful treatments for any cancer very soon! I am convinced this will happen!
Very disappointing, but it appears the Yale University article omitted to reference the corresponding study/research article (or it was not yet published). Likewise, the profile page of the featured researcher, i.e. David A. Braun, MD, PhD, does not appear to contain the respective reference to the study.
"... Though the study is small and early stage, the results are very promising. ...
The study involved nine patients with advanced kidney cancer. All nine had undergone surgery for an advanced form of clear cell renal cell carcinoma (the most common type of kidney cancer) and remained cancer-free for approximately three years and beyond after treatment with a personalized vaccine. Those results demonstrated a robust immune response in patients with stage III and IV cancer who were at a high risk for the cancer returning. These personalized vaccines were designed specifically to arm each person’s immune system to fight the specific cancer-causing genetic mutations found within their tumors. ...
I always try to put myself in the patient’s place before I walk into the examination room. My own mother passed away from cancer when I was in graduate school, but she was diagnosed when I was in middle school, so we lived with it for some time. ...
It took us, on average, about 12 weeks per vaccine, in part because it was the first time we had done it, but also because this is an academic setting—and we really did want to learn. We wanted to be thoughtful because there’s actually a huge amount of nuance to these choices. ...
When will you and your team know the outcomes of the clinical trial’s next phase of research into the personalized vaccines?
It is likely to be two to three years, so by 2027 or 2028. It is a large-scale, randomized international trial involving approximately 270 patients at many large cancer centers, including Yale. ..."
No comments:
Post a Comment